Regulatory T cells in autologous stem cell transplantation for autoimmune disease

Autoimmunity

Volumn 41, Issue 8, 2008, Pages 585-591

  van Wijk, F ^a   Roord, S T ^a   Vastert, B ^a   de Kleer, I ^a   Wulffraat, N ^a   Prakken, B J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autologous stem cell transplantation; Regulatory T cells; Tolerance

Indexed keywords

INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNE DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; INFECTION RISK; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; REGULATORY T LYMPHOCYTE; RELAPSE; REMISSION; REVIEW; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

AUTOIMMUNE DISEASES; HUMANS; IMMUNE TOLERANCE; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, AUTOLOGOUS;

EID: 65449126209     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802200182     Document Type: Review

References (53)

1. Salomon, BL, Sudres, M. and Cohen, JL (2006) Regulatory T cells in graft-versus-host disease. Springer Semin Immunopathol, 28:1, pp. 25-29.
2. Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol, 6:4, pp. 345-352.
3. Katz, SI, Parker, D., Sommer, G. and Turk, JL (1974) Suppressor cells in normal immunisation as a basic homeostatic phenomenon. Nature, 248:449, pp. 612-614.
4. Sakaguchi, S., Sakaguchi, N. Asano, M. et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155:3, pp. 1151-1164.
5. Zheng, Y. and Rudensky, AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol, 8:5, pp. 457-462.
6. Itoh, M., Takahashi, T. Sakaguchi, N. et al. (1999) Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol, 162:9, pp. 5317-5326.
7. Kim, JM, Rasmussen, JP and Rudensky, AY (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol, 8:2, pp. 191-197.
8. von Boehmer, H. (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol, 6:4, pp. 338-344.
9. Apostolou, I. and von Boehmer, H. (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med, 199:10, pp. 1401-1408.
10. Groux, H., O'Garra, A. Bigler, M. et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 389:6652, pp. 737-742.
11. Weiner, HL (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev, 182, pp. 207-214.
12. Muraro, PA, Douek, DC Packer, A. et al. (2005) Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med, 201:5, pp. 805-816.
13. van Gelder M and van Bekkum, DW (1996) Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant, 18:6, pp. 1029-1034.
14. van Bekkum, DW (2000) Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation. Bone Marrow Transplant, 25:4, pp. 357-364.
15. De Kleer, IM, Brinkman, DM Ferster, A. et al. (2004) Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis, 63:10, pp. 1318-1326.
16. Gratwohl, A., Passweg, J. Bocelli-Tyndall, C. et al. (2005) Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant, 35:9, pp. 869-879.
17. Mackall, CL, Bare, CV Granger, LA et al. (1996) Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol, 156:12, pp. 4609-4616.
18. Hirota, K., Hashimoto, M. Yoshitomi, H. et al. (2007) T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med, 204:1, pp. 41-47.
19. Baccala, R. and Theofilopoulos, AN (2005) The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol, 26:1, pp. 5-8.
20. Theofilopoulos, AN, Dummer, W. and Kono, DH (2001) T cell homeostasis and systemic autoimmunity. J Clin Invest, 108:3, pp. 335-340.
21. Krupica Jr, T., Fry, T. J. and Mackall, CL (2006) Autoimmunity during lymphopenia: A two-hit model. Clin Immunol, 120:2, pp. 121-128.
22. Annacker, O., Pimenta-Araujo, R. Burlen-Defranoux, O. et al. (2001) CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol, 166:5, pp. 3008-3018.
23. Hagen, KA, Moses, CT Drasler, EF et al. (2004) A role for CD28 in lymphopenia-induced proliferation of CD4 T cells. J Immunol, 173:6, pp. 3909-3915.
24. Shen, S., Ding, Y. Tadokoro, CE et al. (2005) Control of homeostatic proliferation by regulatory T cells. J Clin Invest, 115:12, pp. 3517-3526.
25. Almeida, AR, Legrand, N., Papiernik, M. and Freitas, AA (2002) Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol, 169:9, pp. 4850-4860.
26. McHugh, RS and Shevach, EM (2002) Cutting edge: Depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol, 168:12, pp. 5979-5983.
27. Herrmann, MM, Gaertner, S. Stadelmann, C. et al. (2005) Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood, 106:5, pp. 1875-1883.
28. Morgan, ME, Flierman, R. van Duivenvoorde, LM et al. (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum, 52:7, pp. 2212-2221.
29. De Kleer, I., Vastert, B. Klein, M. et al. (2006) Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood, 107:4, pp. 1696-1702.
30. Gavin, MA, Clarke, SR Negrou, E. et al. (2002) Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol, 3:1, pp. 33-41.
31. Komatsu N and Hori S (2007) Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras. Proc Natl Acad Sci USA, 104:21, pp. 8959-8964.
32. Condomines, M., Quittet, P. Lu, ZY et al. (2006) Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol, 176:11, pp. 6631-6639.
33. Curotto de Lafaille, MA, Lino, AC, Kutchukhidze, N. and Lafaille, JJ (2004) CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol, 173:12, pp. 7259-7268.
34. Liang, S., Alard, P. Zhao, Y. et al. (2005) Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med, 201:1, pp. 127-137.
35. Wan, YY and Flavell, RA (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA, 102:14, pp. 5126-5131.
36. Allan, SE, Crome, SQ Crellin, NK et al. (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol, 19:4, pp. 345-354.
37. Wang, J., Ioan-Facsinay, A. van der Voort, EI et al. (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol, 37:1, pp. 129-138.
38. Haas, J., Fritzsching, B. Trubswetter, P. et al. (2007) Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol, 179:2, pp. 1322-1330.
39. Small, TN, Papadopoulos, EB Boulad, F. et al. (1999) Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood, 93:2, pp. 467-480.
40. van Amelsfort, JM, Jacobs, KM Bijlsma, JW et al. (2004) CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum, 50:9, pp. 2775-2785.
41. Ruprecht, CR, Gattorno, M. Ferlito, F. et al. (2005) Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med, 201:11, pp. 1793-1803.
42. Feger, U., Luther, C. Poeschel, S. et al. (2007) Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol, 147:3, pp. 412-418.
43. Bettelli, E., Carrier, Y. Gao, W. et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441:7090, pp. 235-238.
44. Pasare C, C and Medzhitov R, R (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science, 299:5609, pp. 1033-1036.
45. Valencia, X., Stephens, G. Goldbach-Mansky, R. et al. (2006) TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood, 108:1, pp. 253-261.
46. Korn, T., Reddy, J. Gao, W. et al. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med, 13:4, pp. 423-431.
47. Szer, I., Kimura, Y., Malleson, P. and Southwood, T. (2006) Arthritis in children & adolescents, Oxford University Press, New York
48. Hoffmann, P., Eder, R. Kunz-Schughart, LA et al. (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25 high regulatory T cells. Blood, 104:3, pp. 895-903.
49. Kreijveld, E., Koenen, HJ, Hilbrands, LB and Joosten, I. (2006) Ex vivo expansion of human CD4+ CD25 high regulatory T cells from transplant recipients permits functional analysis of small blood samples. J Immunol Methods, 314:12, pp. 103-113.
50. Bluestone, JA (2005) Regulatory T-cell therapy: Is it ready for the clinic?. Nat Rev Immunol, 5:4, pp. 343-349.
51. Samsom, JN (2004) Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa. Crit Rev Immunol, 24:3, pp. 157-177.
52. Albani, S. and Prakken, B. (2006) T cell epitope-specific immune therapy for rheumatic diseases. Arthritis Rheum, 54:1, pp. 19-25.
53. Kamphuis, S., Kuis, W. de Jager, W. et al. (2005) Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet, 366:9479, pp. 50-56.